Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
8.18
+0.33 (4.20%)
At close: Sep 26, 2025, 4:00 PM EDT
8.00
-0.18 (-2.21%)
After-hours: Sep 26, 2025, 7:40 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Gvoke, Keveyis and Recorlev
153.36M
Log In
Log In
Log In
Log In
Upgrade
Gvoke, Keveyis and Recorlev Growth
40.36%
Log In
Log In
Log In
Log In
Upgrade
Royalty, Contract and Other
10.55M
Log In
Log In
Log In
Log In
Upgrade
Royalty, Contract and Other Growth
971.07%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
163.91M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
48.68%
Log In
Log In
Log In
Log In
Upgrade